1. Home
  2. EYPT vs EMD Comparison

EYPT vs EMD Comparison

Compare EYPT & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • EMD
  • Stock Information
  • Founded
  • EYPT 1987
  • EMD 2003
  • Country
  • EYPT United States
  • EMD United States
  • Employees
  • EYPT N/A
  • EMD N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • EMD Finance/Investors Services
  • Sector
  • EYPT Industrials
  • EMD Finance
  • Exchange
  • EYPT Nasdaq
  • EMD Nasdaq
  • Market Cap
  • EYPT 594.5M
  • EMD 576.8M
  • IPO Year
  • EYPT 2005
  • EMD N/A
  • Fundamental
  • Price
  • EYPT $8.12
  • EMD $9.98
  • Analyst Decision
  • EYPT Strong Buy
  • EMD
  • Analyst Count
  • EYPT 8
  • EMD 0
  • Target Price
  • EYPT $27.29
  • EMD N/A
  • AVG Volume (30 Days)
  • EYPT 918.1K
  • EMD 248.5K
  • Earning Date
  • EYPT 11-07-2024
  • EMD 01-01-0001
  • Dividend Yield
  • EYPT N/A
  • EMD 10.25%
  • EPS Growth
  • EYPT N/A
  • EMD N/A
  • EPS
  • EYPT N/A
  • EMD N/A
  • Revenue
  • EYPT $45,713,000.00
  • EMD N/A
  • Revenue This Year
  • EYPT N/A
  • EMD N/A
  • Revenue Next Year
  • EYPT N/A
  • EMD N/A
  • P/E Ratio
  • EYPT N/A
  • EMD N/A
  • Revenue Growth
  • EYPT 7.50
  • EMD N/A
  • 52 Week Low
  • EYPT $7.21
  • EMD $7.85
  • 52 Week High
  • EYPT $30.99
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 41.68
  • EMD 49.70
  • Support Level
  • EYPT $7.21
  • EMD $9.96
  • Resistance Level
  • EYPT $8.21
  • EMD $10.11
  • Average True Range (ATR)
  • EYPT 0.49
  • EMD 0.11
  • MACD
  • EYPT -0.02
  • EMD -0.01
  • Stochastic Oscillator
  • EYPT 42.82
  • EMD 27.59

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: